老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
INVESCO PHARMACEUTICALS ETF
125.26
-0.6692
-0.53%
盤後：
125.37
0.1092
+0.09%
19:30 EDT
成交量：
1.18萬
成交額：
148.30萬
市值：
5.47億
市盈率：
6.49
高：
125.75
開：
125.02
低：
125.01
收：
125.93
52周最高：
131.68
52周最低：
90.01
股本：
437.00萬
流通股本：
437.00萬
量比：
0.62
換手率：
0.27%
股息：
1.06
股息率：
0.85%
每股收益(TTM):
19.29
每股收益(LYR):
21.73
淨資產收益率：
23.89%
總資產收益率：
0.60%
市淨率：
1.64
市盈率(LYR):
5.76
資料載入中...
總覽
公司
新聞資訊
公告
FDA批准禮來Mounjaro（替爾泊肽）用於降低2型糖尿病成人患者心血管風險
美股速递
·
08/28
焦點-超越體重：男性紛紛前往美容診所，以實現減肥蜕變
路透中文
·
08/28
金佰利·克拉克尋求歐盟批准這筆400億美元的Kenvue收購交易
路透中文
·
08/28
雅培：董事長兼CEO Ford Robert B行權獲得797664股
南方财经网
·
08/28
歐洲藥品管理局：部分歐盟成員國出現了棕櫚酸帕利哌酮長效注射劑藥品短缺。
智通财经
·
08/27
雅培新一代Amulet 360™設備獲CE認證，助力房顫患者卒中風險防控
美股速递
·
08/27
雅培：Amulet 360產品首批歐洲病例已在德國和丹麥完成手術。
智通财经
·
08/27
市場消息：雅培新一代Amulet 360™封堵器獲CE認證，用於治療存在卒中風險的房顫患者。
智通财经
·
08/27
伯維（ABBV）向EMA遞交Skyrizi克羅恩病治療上市申請
金吾财讯
·
08/27
中國批准強生公司口服銀屑病藥，該藥企表示
路透中文
·
08/27
強生口服Icotrokinra在華獲批，用於治療中重度斑塊狀銀屑病
美股速递
·
08/27
強生公司8月27日宣佈，白介素23（IL-23）受體拮抗劑艾特雅（鹽酸伊可白滯素片）已正式獲得中國國家藥品監督管理局批准
智通财经
·
08/27
強生靶向口服肽類藥物艾特雅在華獲批
智通财经
·
08/27
英國股市——8月27日需關注的因素
路透中文
·
08/27
兩大減肥藥巨頭競逐中國市場：口服減重版司美格魯肽國內上市申請獲受理
智通财经
·
08/27
阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標
路透中文
·
08/27
Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果，共同主要終點及所有關鍵次要終點全面達標
美股速递
·
08/27
艾伯維向歐洲藥品管理局提交Skyrizi®（瑞莎珠單抗）皮下誘導治療申請，針對中重度活動性克羅恩病成人患者
美股速递
·
08/27
中國藥品監管部門受理諾和諾德口服Wegovy上市申請
路透中文
·
08/27
禮來(LLY)股票8月26日開盤下跌3.57%：關鍵驅動因素揭曉
TradingKey中文
·
08/26
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/PJP/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PJP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PJP\",,,,,undefined,":{"symbol":"PJP","market":"US","secType":"STK","nameCN":"INVESCO PHARMACEUTICALS ETF","latestPrice":125.2608,"timestamp":1789761600000,"preClose":125.93,"halted":0,"volume":11830,"hourTrading":{"tag":"盘后","latestPrice":125.37,"preClose":125.2608,"latestTime":"19:30 EDT","volume":14,"amount":1741.3972,"timestamp":1789774205254,"change":0.1092,"changeRate":0.000872,"amplitude":0},"delay":0,"changeRate":-0.0053140633685381045,"floatShares":4370000,"shares":4370000,"eps":19.286062,"marketStatus":"休市中","change":-0.6692,"latestTime":"09-18 16:00:00 EDT","open":125.015,"high":125.745,"low":125.01,"amount":1483026.13095,"amplitude":0.005837,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":19.286062,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":125.93,"sharesOutstanding":3870000,"nav":125.88655,"aum":548971333.97,"dividendRate":0.008462,"bidAskSpread":0.000885,"preHourTrading":{"tag":"盘前","latestPrice":125.93,"preClose":125.93,"latestTime":"04:00 EDT","volume":2,"amount":251.86,"timestamp":1789718420291,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":125.37,"preClose":125.2608,"latestTime":"19:30 EDT","volume":14,"amount":1741.3972,"timestamp":1789774205254,"change":0.1092,"changeRate":0.000872,"amplitude":0},"volumeRatio":0.6176965150723346,"impliedVol":0.2016,"impliedVolPercentile":0.992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PJP\",,,,,undefined,":{"symbol":"PJP","floatShares":4370000,"roa":"0.60%","roe":"23.89%","lyrEps":21.734944,"volumeRatio":0.6176965150723346,"shares":4370000,"dividePrice":1.06,"high":125.745,"amplitude":0.005837,"preClose":125.93,"low":125.01,"week52Low":90.01,"pbRate":"1.64","psRate":"107.99","week52High":131.675,"institutionHeld":0.824,"latestPrice":125.2608,"eps":19.286062,"divideRate":0.008462,"volume":11830,"delay":0,"ttmEps":19.286062,"open":125.015,"prevYearClose":104.54,"prevWeekClose":124.09,"prevMonthClose":127.49,"prevQuarterClose":118.4468,"fiveDayClose":124.09,"twentyDayClose":128.886,"sixtyDayClose":114.9005},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PJP\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"PJP","amount":0.30136,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"PJP","amount":0.27334,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PJP","amount":0.30902,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PJP","amount":0.24629,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PJP","amount":0.23633,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PJP\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.20736,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.03683,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.15586,"currency":"USD"},{"executeDate":"2017-09-18","recordDate":"2017-09-19","paymentDate":"2017-09-29","value":0.12281,"currency":"USD"},{"executeDate":"2018-03-19","recordDate":"2018-03-20","paymentDate":"2018-03-29","value":0.05634,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PJP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PJP\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1168986397","title":"FDA批准禮來Mounjaro（替爾泊肽）用於降低2型糖尿病成人患者心血管風險","url":"https://stock-news.laohu8.com/highlight/detail?id=1168986397","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168986397?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 19:02","pubTimestamp":1787914941,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已正式批准礼来旗下药物 Mounjaro的新适应症——用于降低伴有2型糖尿病的成年患者心血管事件风险。这一决定为众多糖尿病合并心血管高风险人群带来了新的治疗选项。此次获批标志着替尔泊肽在代谢与心血管交叉领域的又一重要进展。随着适应症范围的扩大，替尔泊肽的临床使用覆盖面将更加广泛，有望进一步重塑2型糖尿病合并心血管疾病患者的治疗格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4588","IXJ","SG9999014880.SGD","IE00B1XK9C88.USD","LU0385154629.USD","IE00BFSS8Q28.SGD","LU0058720904.USD","SG9999014898.SGD","LU0672654240.SGD","LU1804176565.USD","LU2552382215.SGD","LU2237443978.SGD","WDNA","IE00BJJMRX11.SGD","LU0640476718.USD","LU2756315664.SGD","LU0943347566.SGD","LU1868837136.USD","LU0320765059.SGD","LU0820561909.HKD","LU2746668461.USD","LU2324357040.USD","LU2271345857.HKD","LU0786609619.USD","LLYX","LU1366192091.USD","BK4516","LU0823416689.USD","SGXZ51526630.SGD","LU2357305700.SGD","PJP","LU0122379950.USD","LU2265009873.SGD","LU1623119135.USD","LU2361044865.SGD","IE00B1BXHZ80.USD","LU2237443382.USD","LU0345770308.USD","IE0001KFT4U8.USD","LU1267930730.SGD","IYH","LU2471134523.USD","XLV","LLYZ","LU0471298694.HKD","LU1057294990.SGD","GB00BDT5M118.USD","LU2361045086.USD","LU2552382132.HKD","IE00B2B36J28.USD","LU2168564065.EUR","IHE","IE00BJT1NW94.SGD","LU0964807845.USD","LU1323610961.USD","LU1988902786.USD","LU1868836914.USD","OZEM","LU1145028129.USD","IE00B4R5TH58.HKD","LU2462157665.USD","ELIL","LU0256863902.USD","BK4599","LU0238689110.USD","LU2462591350.SGD","FHLC","SG9999013999.USD","LU1280957306.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","THNR","LU0234572021.USD","LU2471134879.HKD","LU0316494557.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2108987350.USD","LU1551013425.SGD","SGXZ31699556.SGD","LU2112291526.USD","LU0323591593.USD","LLII","LU1127390331.HKD","LU1291159041.SGD","IE00BJJMRY28.SGD","IE00BKPKM429.USD","TRUH","BK4007","IE0002141913.USD","ILDR","LU0354030511.USD","LU0158827781.USD","LU1035775433.USD","LU2089284900.SGD","LU0820562030.AUD","LU1868837300.USD","LU0198837287.USD","IE0004445239.USD","LU2213496289.HKD","LU0096364046.USD","LU0061475181.USD","LU2023250504.SGD","LU2087625088.SGD","LU0225283273.USD","LU2471134952.CNY","SG9999001176.SGD","LU0097036916.USD","SG9999014914.USD","LU2211815571.USD","LU2237438978.USD","LU2746668974.SGD","LU0683600562.USD","LU1023059063.AUD","LU0079474960.USD","LU1720051108.HKD","LU2168564495.EUR","IE00BJLML261.HKD","LU0417517546.SGD","LU2264538146.SGD","SG9999015978.USD","LU1691799644.USD","AGNG","LU0823434583.USD","LU0289739699.SGD","LU2237443895.HKD","SG9999017495.SGD","LU0354030438.USD","LU0432979614.USD","IE00BK4W5M84.HKD","LU0256863811.USD","LU2089984988.USD","HRTS","LU2360106947.USD","LU1720051017.SGD","LU2361044949.HKD","LU0109394709.USD","LU0320765992.SGD","LU0345770993.USD","LU0210536198.USD","LU2552382058.USD","LU1868836591.USD","MEDI","MHIP","LU2417539215.USD","LU2468319806.SGD","LU0109391861.USD","LU0174119429.USD","IE00BN29S564.USD","LU0882574055.USD","IE00B4JS1V06.HKD","LU0353189763.USD","CANC","IE00B7KXQ091.USD","LU2023250330.USD","LU2750360641.GBP","SGXZ57979304.SGD","LU0823434740.USD","SG9999015986.USD","LU2461242641.AUD","LU2602419157.SGD","LU1551013342.USD","LU2750360997.AUD","LU1979441026.SGD","LU0006306889.USD","LU0133085943.USD","LU1548497426.USD","LU2111349929.HKD","LU0820561818.USD","BK4585","SGXZ99366536.SGD","SG9999001176.USD","LU0158827948.USD","LU2236285917.USD","LU0787776722.HKD","SGXZ81514606.USD","LU0094547139.USD","JDOC","LU1629891620.HKD","IE0005OL40V9.USD","LU2168564222.USD","LU2491050071.SGD","LU2896262040.SGD","LU2023251221.USD","LU1232071149.USD","LU2089283258.USD","LU2168563687.JPY","LU2028103732.USD","TMED","CURE","MEDX","LU0203201768.USD","LU0889565916.HKD","LU1064131342.USD","IE00BFSS7M15.SGD","LU0106261372.USD","LU1974910355.USD","SG9999015945.SGD","LU1069344957.HKD","LU1712237335.SGD","LU2237443465.HKD","PPH","RXL","LU0456855351.SGD","LU0353189680.USD","LU1868836757.USD","GDOC","LU0708995401.HKD","LU1093756325.SGD","LU2168564149.EUR","IE00BK4W5L77.USD","LU1061106388.HKD","LU2237443549.SGD","FTXH","VHT","IE00B775H168.HKD","BK4533","LU0689472784.USD","IE00BWXC8680.SGD","LU2237443622.USD","LU0471298777.SGD","LU2756315318.SGD","SG9999018865.SGD","BK4534","LU0114720955.EUR","LLY","LU1814569148.SGD","LU1093756168.USD","LU0466842654.USD","LU0882574139.USD","LU2063271972.USD","LU0266013472.USD","LU2456880835.USD","SG9999015952.SGD","IE0004445015.USD","LU2471134796.USD","SG9999018857.SGD","LU2106854487.HKD","LU2491049909.HKD","LU0203202063.USD","LU2491050154.USD","LU1989771016.USD","SG9999014906.USD","ELIS","LU1917777945.USD","IE00BKDWB100.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662693000","title":"焦點-超越體重：男性紛紛前往美容診所，以實現減肥蜕變","url":"https://stock-news.laohu8.com/highlight/detail?id=2662693000","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662693000?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 18:01","pubTimestamp":1787911288,"startTime":"0","endTime":"0","summary":"焦点-超越体重：男性纷纷前往美容诊所，以实现减肥蜕变外科医生指出，社交媒体和不断变化的男性气概规范是男性美容需求日益增长的原因GoodRx数据显示，男性目前占减肥药使用者的28.3%医生预计，随着包括口服药在内的新型减肥药问世，需求将进一步增长Sriparna Roy路透8月28日-患者和整形外科医生表示，随着畅销减肥药帮助更多美国男性瘦身，越来越多的人正在寻求针对皮肤松弛、脱发和牙齿问题的美容治疗，以完成他们的身体蜕变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4T44P0PP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GB00BDT5M118.USD","LLYX","LU2357305700.SGD","SG9999013999.USD","SGXZ51526630.SGD","IE00BFTCPJ56.SGD","CANC","HRTS","LU1232071149.USD","LU1720051017.SGD","LU2237443382.USD","LU0158827948.USD","LU2237443895.HKD","SG9999014914.USD","PPH","LU2756315318.SGD","LU0109391861.USD","LU2468319806.SGD","LU1623119135.USD","IHE","LU2361044865.SGD","NVOX","IE00BK4W5M84.HKD","LU1814569148.SGD","LU2360106947.USD","IE00BJJMRY28.SGD","LU0345770993.USD","NVOC","TRUH","LU0097036916.USD","LU1712237335.SGD","LU0708995401.HKD","LU0820561909.HKD","LU0203202063.USD","LU1979441026.SGD","LU2471134952.CNY","LU1551013425.SGD","LU2168563687.JPY","BK4516","ELIS","LU1280957306.USD","LU2750360997.AUD","LU0964807845.USD","LU1035775433.USD","LU1145028129.USD","LU1267930730.SGD","LU2746668461.USD","LU2168564495.EUR","SG9999014906.USD","LU1069344957.HKD","LU1868836757.USD","LU2236285917.USD","LU2168564222.USD","BK4007","LU2265009873.SGD","IE00B4R5TH58.HKD","LU1323610961.USD","LU2087625088.SGD","IE00BKDWB100.SGD","FTXH","LU0122379950.USD","LU0354030511.USD","LU2471134523.USD","LU2471134796.USD","IXJ","LU0266013472.USD","RXL","LU2462591350.SGD","IE00BJT1NW94.SGD","LU2462157665.USD","IE00BK4W5L77.USD","LU0354030438.USD","LU0158827781.USD","LU1093756168.USD","LU0006306889.USD","LU2746668974.SGD","BK4532","LU0823434740.USD","LU2089283258.USD","LU2237443465.HKD","LU0787776722.HKD","LU2491050154.USD","SG9999014898.SGD","LU2896262040.SGD","IE0001KFT4U8.USD","LU1868836914.USD","GDOC","LU1868837300.USD","LU1983299246.USD","LU2271345857.HKD","IE00B1XK9C88.USD","IE00BWXC8680.SGD","IE0004445239.USD","IE00B775H168.HKD","LU2168564065.EUR","LU0689472784.USD","IE00BKPKM429.USD","LU0094547139.USD","CURE","BK4534","LU1917777945.USD","SGXZ99366536.SGD","LU2491049909.HKD","LU0353189680.USD","LU2237438978.USD","IE00BKVL7J92.USD","LU0061475181.USD","LU0820562030.AUD","LU2471134879.HKD","IE00B7KXQ091.USD","LU1093756325.SGD","LU2361044949.HKD","LU0154236417.USD","LU2028103732.USD","LU2237443622.USD","LU2168564149.EUR","VHT","LU0114720955.EUR","LU2461242641.AUD","LU0385154629.USD","LU2023250330.USD","SG9999015952.SGD","WDNA","LU0889565916.HKD","FHLC","LU0432979614.USD","IE00BFSS8Q28.SGD","LU0133085943.USD","LU0289739699.SGD","LU2211815571.USD","LU0353189763.USD","LU1061106388.HKD","THNR","LU0058720904.USD","TMED","LU2602419157.SGD","ILDR","LU1629891620.HKD","SG9999018857.SGD","BK4588","AGNG","BK4585","LLII","LU1691799644.USD","LU1974910355.USD","PJP","LU0210536198.USD","SG9999001176.SGD","IE0002141913.USD","LU2213496289.HKD","LU1551013342.USD","LU1988902786.USD","LU0417517546.SGD","LU0203201768.USD","LU0198837287.USD","LU1023059063.AUD","IE0005OL40V9.USD","LU1127390331.HKD","SG9999015986.USD","LU0079474960.USD","LU0820561818.USD","LU1064131342.USD","LU0256863811.USD","SG9999018865.SGD","IE00BN29S564.USD","IE00B1BXHZ80.USD","LLY","LU0943347566.SGD","OZEM","NVOH","SG9999015945.SGD","IYH","ELIL","LU0256863902.USD","LU2264538146.SGD","LU0096364046.USD","IE00BJJMRX11.SGD","LU2456880835.USD","LU2324357040.USD","LU2756315664.SGD","IE0004445015.USD","BK4581","NVO","LU2111349929.HKD","LLYZ","SG9999015978.USD","LU1366192091.USD","IE0009355771.USD","LU2106854487.HKD","IE00B4JS1V06.HKD","IE00BJLML261.HKD","LU2552382058.USD","SG9999001176.USD","XLV","LU0234572021.USD","LU0320765992.SGD","LU0316494557.USD","LU0882574139.USD","LU0683600562.USD","LU0320765059.SGD","IE00B2B36J28.USD","IE00BFSS7M15.SGD","BK4599","LU1720051108.HKD","LU0823416689.USD","LU2237443549.SGD","LU2750360641.GBP","SG9999014880.SGD","LU2112291526.USD","LU0225283273.USD","LU0640476718.USD","LU0823434583.USD","LU2089284900.SGD","LU0109394709.USD","LU0786609619.USD","LU0471298694.HKD","LU2552382132.HKD","SG9999017495.SGD","IE00BJJMRZ35.SGD","LU0882574055.USD","LU2491050071.SGD","LU0672654240.SGD","LU2237443978.SGD","SGXZ81514606.USD","LU1548497426.USD","SGXZ31699556.SGD","MHIP","LU0106261372.USD","LU1989771016.USD","JDOC","LU1291159041.SGD","LU2417539215.USD","SGXZ57979304.SGD","LU2108987350.USD","LU0345770308.USD","LU1057294990.SGD","MEDI","LU0323591593.USD","LU0466842654.USD","LU1868836591.USD","LU2063271972.USD","LU0471298777.SGD","LU1868837136.USD","LU2089984988.USD","LU2552382215.SGD","BK4533","LU2023250504.SGD","LU0456855351.SGD","LU2361045086.USD","LU1804176565.USD","LU2023251221.USD","LU0238689110.USD","MEDX","IE00BZ1G4Q59.USD","LU0174119429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662057892","title":"金佰利·克拉克尋求歐盟批准這筆400億美元的Kenvue收購交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2662057892","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662057892?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 15:49","pubTimestamp":1787903373,"startTime":"0","endTime":"0","summary":"金佰利·克拉克寻求欧盟批准这笔400亿美元的Kenvue收购交易路透8月28日-欧盟委员会网站上的文件显示，金佰利·克拉克KMB.O已向欧盟监管机构申请批准其拟以400亿美元 (link) 收购泰诺（Tylenol）制造商肯维（Kenvue）的交易。金佰利·克拉克于去年11月宣布了此次收购计划。该公司当时表示，该交易预计将于2026年下半年完成。金佰利·克拉克预计该交易将带来21亿美元的年度成本节约。该公司表示，通过收购肯维旗下从李施德林漱口水到艾维诺、露得清等护肤品牌的庞大产品组合，合并后公司预计将实现约320亿美元的年收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4S44P0IB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","BK4568","LU0114720955.EUR","LU2417539215.USD","TRUH","LU0545562505.USD","PJP","SG9999002232.USD","LU1585245621.USD","LU2456880835.USD","BK4588","LU1506573853.SGD","GLAM","LU0058720904.USD","IYH","RSPS","VHT","LU2430703095.HKD","LU0882574055.USD","LU1732799900.SGD","LU1043141123.HKD","LU2471134952.CNY","LU2602419157.SGD","BK4585","LU0289739699.SGD","LU2213496289.HKD","JDOC","LU0640476718.USD","FTXH","FHLC","IHE","IE00B42XCP33.USD","LU2129689431.USD","KMB","LU1244550494.USD","LU0320765646.SGD","KVUE","LU0795875086.SGD","BMED","IXJ","IE00BDGV0183.EUR","MEDX","LU0683600562.USD","RXL","GDOC","JNJ","LU2347655156.SGD","XLV","LU1023059063.AUD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662030607","title":"雅培：董事長兼CEO Ford Robert B行權獲得797664股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662030607","media":"南方财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662030607?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 09:45","pubTimestamp":1787881500,"startTime":"0","endTime":"0","summary":"南财智讯8月28日电，雅培（ABBOTTLABORATORIES）（纽约证券交易所：ABT）董事长兼CEOFordRobertB提交Form4持股变动声明。8月25日，FordRobertB通过4笔交易合计行权获得797664股普通股，成交价格区间44.4至116.19美元，加权均价约84.94美元，投入约6775.07万美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608283857710688.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608283857710688.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2211815571.USD","BK4581","LU2237957811.SGD","LU1691799644.USD","LU0058720904.USD","IE00B2B36J28.USD","LU1057294990.SGD","LU0320765489.SGD","ABT","IE0009355771.USD","LU1721429402.USD","BK4566","LU0234572021.USD","SG9999002224.SGD","BK4504","IE00BFTCPJ56.SGD","LU0122379950.USD","IE00BJJMRZ35.SGD","BK4585","LU0208291251.USD","LU1061106388.HKD","BK4082","PJP","LU2324357040.USD","LU1989763690.USD","LU1721429741.USD","SGXZ41872573.SGD","BK4592","IE0002141913.USD","LU1914381329.SGD","LU0868494617.USD","BK4568","IE00BJT1NW94.SGD","BK4588","LU0882574055.USD","LU0170899867.USD","LU1989763427.SGD","LU0289739699.SGD","LU1023059063.AUD","SG9999002232.USD","IHI","SGXZ23171101.USD","BK4533","LU2468319806.SGD","TMED","LU0211331839.USD","LU0114720955.EUR","LU0070302665.USD","LU0266013472.USD","LU2237957902.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662839400","title":"歐洲藥品管理局：部分歐盟成員國出現了棕櫚酸帕利哌酮長效注射劑藥品短缺。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662839400","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662839400?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 21:49","pubTimestamp":1787838570,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102966985","title":"雅培新一代Amulet 360™設備獲CE認證，助力房顫患者卒中風險防控","url":"https://stock-news.laohu8.com/highlight/detail?id=1102966985","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102966985?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 21:05","pubTimestamp":1787835918,"startTime":"0","endTime":"0","summary":"雅培公司新一代Amulet 360™设备已成功获得CE认证标志，这一里程碑式的进展将为心房颤动患者带来卒中风险管理的全新解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","BK4568","IE00BFTCPJ56.SGD","IHI","LU1914381329.SGD","LU2324357040.USD","LU0208291251.USD","IE00BJJMRZ35.SGD","ABT","IE0002141913.USD","LU0070302665.USD","BK4585","BK4592","LU1721429741.USD","BK4581","BK4082","LU2237957811.SGD","SGXZ41872573.SGD","LU1989763690.USD","LU2133065610.SGD","BK4566","PJP","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0234572021.USD","LU1721429402.USD","LU2112291526.USD","LU1691799644.USD","LU1023059063.AUD","TMED","LU0868494617.USD","LU2237957902.USD","IE00B2B36J28.USD","SGXZ23171101.USD","LU2211815571.USD","LU0114720955.EUR","IE0009355771.USD","BK4504","LU0266013472.USD","LU0432979614.USD","LU2089984988.USD","LU0170899867.USD","LU0882574055.USD","BK4533","LU2468319806.SGD","LU0211331839.USD","LU0320765489.SGD","BK4588","SG9999002224.SGD","SG9999002232.USD","LU1057294990.SGD","SG9999004303.SGD","LU1989763427.SGD","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662700057","title":"雅培：Amulet 360產品首批歐洲病例已在德國和丹麥完成手術。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662700057","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662700057?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 21:04","pubTimestamp":1787835861,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2112291526.USD","BK4588","LU2237957811.SGD","LU0114720955.EUR","LU1023059063.AUD","BK4568","LU1989763690.USD","SG9999002232.USD","IE00B4R5TH58.HKD","PJP","TMED","SGXZ41872573.SGD","SG9999004303.SGD","BK4581","LU0234572021.USD","LU1691799644.USD","IHI","LU0432979614.USD","IE00B2B36J28.USD","LU0882574055.USD","LU2237957902.USD","LU0058720904.USD","LU0289739699.SGD","LU1989763427.SGD","LU2324357040.USD","LU0320765489.SGD","LU1721429402.USD","IE0009355771.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","BK4533","LU0266013472.USD","LU2211815571.USD","LU2133065610.SGD","BK4592","LU1721429741.USD","LU0070302665.USD","SG9999002224.SGD","SGXZ23171101.USD","ABT","LU0170899867.USD","LU1061106388.HKD","LU1914381329.SGD","LU2089984988.USD","IE0002141913.USD","BK4566","LU0211331839.USD","IE00BFTCPJ56.SGD","BK4585","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662700754","title":"市場消息：雅培新一代Amulet 360™封堵器獲CE認證，用於治療存在卒中風險的房顫患者。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662700754","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662700754?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 21:03","pubTimestamp":1787835814,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PJP","LU1721429402.USD","LU0266013472.USD","LU1691799644.USD","SG9999002232.USD","LU2133065610.SGD","SGXZ23171101.USD","LU2468319806.SGD","SG9999002224.SGD","LU2237957811.SGD","LU0882574055.USD","LU0070302665.USD","LU1914381329.SGD","SG9999004303.SGD","LU0211331839.USD","IE00BJJMRZ35.SGD","BK4581","LU0114720955.EUR","IE0009355771.USD","LU0122379950.USD","LU0170899867.USD","BK4566","LU1061106388.HKD","LU1721429741.USD","BK4592","LU0289739699.SGD","TMED","BK4082","BK4585","IE0002141913.USD","LU1057294990.SGD","BK4588","BK4568","IE00BFTCPJ56.SGD","LU1989763427.SGD","BK4533","LU0320765489.SGD","IE00BJT1NW94.SGD","LU0234572021.USD","ABT","LU0432979614.USD","LU1989763690.USD","LU1023059063.AUD","BK4504","LU0208291251.USD","IE00B2B36J28.USD","SGXZ41872573.SGD","LU2211815571.USD","IE00B4R5TH58.HKD","IHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662639772","title":"伯維（ABBV）向EMA遞交Skyrizi克羅恩病治療上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2662639772","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662639772?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:56","pubTimestamp":1787821007,"startTime":"0","endTime":"0","summary":"Skyrizi此前已经在银屑病、银屑病关节炎等多个自身免疫疾病领域拿到欧洲地区的获批资质，如若本次克罗恩病适应症顺利获批，将进一步拓宽该产品在欧洲炎症性肠病赛道的市场空间。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305377","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965508806.USD","IE000F7OJYX1.SGD","LU0234572021.USD","IXJ","LU1267930573.SGD","LU2125909247.SGD","IPOS","LU0058720904.USD","IYH","FTXH","LU0198837287.USD","LU0472753341.HKD","EMA","LU2237443622.USD","LU0114720955.EUR","LU1585245621.USD","LU0128525929.USD","LU0417517546.SGD","LU2087621335.USD","LU2125909593.SGD","MEDX","FHLC","PPH","LU0661504455.SGD","LU1989771016.USD","LU0882574055.USD","LU2023251221.USD","SG9999001440.SGD","LU1839511570.USD","LU1236620750.USD","ABBV","LU0289739699.SGD","LU0985320562.USD","XLV","LU2089283258.USD","RXL","SG9999011175.SGD","LU1732799900.SGD","JDOC","PJP","GLAM","BK4533","LU1236620834.HKD","IE0004445239.USD","IE00BLSP4239.USD","BK4559","TRUH","LU2133065610.SGD","VHT","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774757","title":"中國批准強生公司口服銀屑病藥，該藥企表示","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774757","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774757?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:54","pubTimestamp":1787820888,"startTime":"0","endTime":"0","summary":"中国批准强生公司口服银屑病药，该药企表示路透上海8月27日-强生公司（JNJ.N）周四表示，其口服药物伊科特罗金拉（icotrokinra）已在中国获批用于治疗中重度斑块型银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4S44O0R7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2430703178.SGD","LU2023250330.USD","LU0345770308.USD","LU2471134796.USD","LU2896262040.SGD","IE00B2B36J28.USD","LU0210536198.USD","LU1074936037.SGD","BK4588","RXL","LU0162691827.USD","LU2236285917.USD","LU0640476718.USD","LU1983299246.USD","LU2487616109.SGD","LU0053666078.USD","FTXH","SG9999001440.SGD","XLV","JNJ","LU2089984988.USD","LU2456880835.USD","GDOC","IHE","LU0545562505.USD","IE00BGHQF631.EUR","IE00BZ1G4Q59.USD","IXJ","LU0882574055.USD","SG9999013999.USD","VHT","LU0345769631.USD","LU1244550494.USD","LU1032955483.USD","TRUH","LU2602419157.SGD","SG9999001176.SGD","JDOC","LU2471134952.CNY","MEDX","PJP","LU1506573853.SGD","IYH","LU0124676726.USD","LU1228905540.USD","FHLC","LU1291159041.SGD","BMED","LU1221951046.USD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113704178","title":"強生口服Icotrokinra在華獲批，用於治療中重度斑塊狀銀屑病","url":"https://stock-news.laohu8.com/highlight/detail?id=1113704178","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113704178?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:49","pubTimestamp":1787820549,"startTime":"0","endTime":"0","summary":"强生公司宣布，其口服药物Icotrokinra已获得中国监管部门的批准，用于治疗中重度斑块状银屑病。这一消息通过官方声明对外发布。\n该药物为患者提供了一种新的治疗选择，尤其针对那些患有中度至重度斑块状银屑病的成人群体。此次获批标志着强生在中国皮肤病治疗领域迈出了重要一步。\n值得注意的是，Icotrokinra作为一种口服疗法，相较于传统的注射或外用药物，可能为患者带来更多便利性和依从性。强生方面表示，将继续致力于为全球患者提供创新的医疗解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2756315318.SGD","BK4532","LU1066051498.USD","IE0002270589.USD","LU1778281490.HKD","LU1228905540.USD","MEDX","LU1196500208.SGD","LU1935042991.SGD","LU2750360997.AUD","BK4504","IE000M9KFDE8.USD","LU0122379950.USD","LU1221951046.USD","LU2505996681.GBP","GDOC","LU1551013342.USD","LU0210536198.USD","LU0426412945.USD","LU2133065610.SGD","LU1674673428.USD","IE00BVYPNW00.USD","IE00BJT1NW94.SGD","LU0943347566.SGD","LU1145028129.USD","LU0320765646.SGD","LU1244550494.USD","IE000BZT7R73.USD","IE00B3T34201.USD","LU0289739699.SGD","BMED","LU0964807845.USD","BK4007","IE00BLSP4239.USD","SG9999002232.USD","XLV","LU0234570918.USD","LU0787776722.HKD","LU1043141396.HKD","LU0792757196.USD","IE00B19Z3B42.SGD","LU2456880835.USD","LU2602419157.SGD","BK4550","LU1032955483.USD","IE00BLSP4452.SGD","LU2430703178.SGD","LU1043141123.HKD","LU1629891620.HKD","LU2112291526.USD","FHLC","LU0058720904.USD","IE00B2B36J28.USD","LU2756315664.SGD","LU0426417589.USD","IE000WAW04H5.SGD","LU1244550577.SGD","LU2417539215.USD","BK4585","LU1280957306.USD","LU1983299246.USD","IE000SO60NU8.SGD","LU2347655156.SGD","BK4592","LU1121112475.USD","LU2430703251.USD","BK4568","IE00BFXG1179.USD","BK4559","BK4588","LU0882574055.USD","LU1894683348.USD","LU2403377893.USD","RXL","IE00B19Z3581.USD","LU0345769128.USD","LU0820561818.USD","LU1430594728.SGD","LU1894683264.USD","LU1506573853.SGD","LU1023059063.AUD","LU1059921491.USD","FTXH","LU2468319806.SGD","LU2471134952.CNY","LU2750360641.GBP","LU2487616109.SGD","IE00BKVL7J92.USD","LU0203345920.USD","LU1732799900.SGD","LU1914381329.SGD","LU2213496289.HKD","LU2471134523.USD","LU2471134879.HKD","SG9999001176.USD","IE00B42XCP33.USD","LU0466842654.USD","IE0000B7K699.USD","IE00B3PB1722.GBP","JNJ","VHT","LU0689626769.HKD","LU1267930813.SGD","LU2023250330.USD","IE00BSNM7G36.USD","LU0640476718.USD","SGXZ57979304.SGD","LU0345769631.USD","LU0432979614.USD","LU2129689431.USD","IE0001KFT4U8.USD","LU0234572021.USD","LU2129689605.HKD","LU0889566641.SGD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU1066051225.USD","LU1929549753.HKD","LU1989771016.USD","PJP","LU0985320562.USD","LU2505996509.AUD","LU0994945656.USD","IE00BN8TJ469.HKD","IE00B1BXHZ80.USD","LU0820561909.HKD","LU0345770308.USD","SG9999001440.SGD","LU0210528500.USD","IE00B7SZLL34.SGD","LU1066051811.HKD","LU1585245621.USD","LU2129689514.USD","LU0912757837.SGD","IE00BZ1G4Q59.USD","LU0203347892.USD","LU0545562505.USD","IE00B4R5TH58.HKD","LU2236285917.USD","LU2592432038.USD","BK4533","IE00BBT3K403.USD","LU2471134796.USD","LU1032466523.USD","LU0053666078.USD","LU1496350502.SGD","IE00BDGV0183.EUR","LU0162691827.USD","LU0124676726.USD","BK4581","LU0795875086.SGD","LU0070217475.USD","LU1551013425.SGD","LU2430703095.HKD","BK4534","LU1057294990.SGD","LU0820562030.AUD","IE0009355771.USD","SG9999001176.SGD","LU1732800096.USD","LU0795875169.SGD","IE00BGHQF631.EUR","SG9999002224.SGD","IE000F7OJYX1.SGD","IYH","LU1066053197.SGD","IE00BJJMRZ35.SGD","SG9999013999.USD","LU0683600562.USD","IHE","LU0072461881.USD","LU1074936037.SGD","SGXZ80539844.SGD","IE000MB6IJN5.SGD","LU0098860793.USD","LU1228905037.USD","LU2089984988.USD","LU1291159041.SGD","IE0002141913.USD","IXJ","LU1221951129.SGD","LU0689472784.USD","LU2896262040.SGD","LU1718418525.SGD","IE00BVYPNV92.GBP","LU1674673691.USD","LU0345770993.USD","LU1244550221.USD","TRUH","LU0114720955.EUR","LU1162221912.USD","JDOC","IE0034235303.USD","LU1261432733.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774566","title":"強生公司8月27日宣佈，白介素23（IL-23）受體拮抗劑艾特雅（鹽酸伊可白滯素片）已正式獲得中國國家藥品監督管理局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774566","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774566?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:40","pubTimestamp":1787820043,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B4R5TH58.HKD","LU1228905037.USD","LU1551013342.USD","IXJ","LU2896262040.SGD","LU2417539215.USD","JNJ","IE00B3T34201.USD","SG9999013999.USD","LU2471134523.USD","LU2505996509.AUD","IYH","BK4532","FTXH","IE0001KFT4U8.USD","LU0912757837.SGD","LU1506573853.SGD","GDOC","BK4534","SG9999001176.SGD","SGXZ80539844.SGD","LU1244550494.USD","LU2468319806.SGD","LU0683600562.USD","LU0820562030.AUD","MEDX","LU1261432733.SGD","FHLC","BK4007","VHT","LU1989771016.USD","IE00BSNM7G36.USD","LU0882574055.USD","IE0002270589.USD","LU0985320562.USD","XLV","RXL","LU1228905540.USD","LU0964807845.USD","IE00BFXG1179.USD","IHE","JDOC","PJP","LU2112291526.USD","LU1074936037.SGD","LU1221951129.SGD","TRUH","LU2403377893.USD","BMED","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662777108","title":"強生靶向口服肽類藥物艾特雅在華獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2662777108","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662777108?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:33","pubTimestamp":1787819601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1059921491.USD","MEDX","IE000M9KFDE8.USD","LU2023250330.USD","LU1629891620.HKD","LU0994945656.USD","RXL","IE000SO60NU8.SGD","LU2471134796.USD","LU2430703178.SGD","LU0070217475.USD","JDOC","LU0683600562.USD","LU2487616109.SGD","XLV","IE000WAW04H5.SGD","LU0689472784.USD","IXJ","LU1496350502.SGD","GDOC","LU0889566641.SGD","BK4533","PJP","LU0114720955.EUR","LU2129689514.USD","LU2133065610.SGD","LU1430594728.SGD","LU2756315664.SGD","BK4007","BK4568","VHT","LU1043141396.HKD","FHLC","LU2750360997.AUD","LU1244550494.USD","IYH","LU0466842654.USD","IE00BVYPNW00.USD","LU1718418525.SGD","LU1023059063.AUD","LU1221951046.USD","LU2430703095.HKD","TRUH","BMED","LU2403377893.USD","FTXH","IHE","JNJ","IE00B1BXHZ80.USD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775484","title":"英國股市——8月27日需關注的因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775484","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775484?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:53","pubTimestamp":1787813617,"startTime":"0","endTime":"0","summary":"更新 1-英国股市——8月27日需关注的因素新增新闻报导，更新期货行情路透8月27日-预计周四英国富时100指数.FTSE将低开，期货FFIc1下跌0.4%。*7月汽车产量：行业数据显示，受出口疲软及部分工厂提前进行夏季检修停产影响，英国7月汽车产量 同比下降11.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","CRDA.UK","PRU.UK","LU0047713382.USD","LU2293690082.USD","IBBQ","LU1267930573.SGD","LU0171293334.USD","LU0075056555.USD","LU0345777147.USD","LU0969580561.USD","AZN.UK","LU1880407132.USD","LU2089984988.USD","BK4139","LU0211326755.USD","SG9999001176.SGD","LU0310800379.SGD","LU1989771016.USD","LU1057294990.SGD","BBH","LU1119994496.HKD","BK5105","LU0857590862.USD","TBXU","LU0345780950.USD","LU0949170426.SGD","LU1267930227.SGD","LU0122379950.USD","03165","AMGN","LU0171276677.USD","SGXZ57979304.SGD","LU0889565916.HKD","PPH.UK","BK4585","LU0553294199.USD","LU1989772923.USD","LU1104425308.USD","LU1355424745.HKD","PJP","GAW.UK","GLEN.UK","PBE","LU0792757196.USD","HFD.UK","IE0034235188.USD","BIB","IBB","LU0963555726.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662677565","title":"兩大減肥藥巨頭競逐中國市場：口服減重版司美格魯肽國內上市申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2662677565","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662677565?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:41","pubTimestamp":1787812915,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0210536198.USD","MEDX","LU2089984988.USD","LU1023059063.AUD","LU0432979614.USD","FHLC","LU0323591593.USD","LLYX","LU0345770993.USD","LU0097036916.USD","LU2112291526.USD","LU0266013472.USD","LU2213496289.HKD","MEDI","LLY","LU0708995401.HKD","LU0683600562.USD","LU1868837136.USD","AGNG","LU2750360641.GBP","LU1057294990.SGD","LU2462157665.USD","NVOX","VHT","LU2236285917.USD","LU1093756325.SGD","LU0094547139.USD","LU0122379950.USD","GDOC","LU2361045086.USD","NVOC","LU2324357040.USD","LU2237443382.USD","IE00BN29S564.USD","LU2471134952.CNY","NVO","LU1917777945.USD","LU2417539215.USD","IE0009355771.USD","IE00B1BXHZ80.USD","IE00B1XK9C88.USD","LLII","LU0471298694.HKD","LU2089284900.SGD","SG9999018865.SGD","LU2265009873.SGD","IE00BJJMRX11.SGD","LU0385154629.USD","LU0061475181.USD","LU1551013425.SGD","BK4532","IE00BK4W5M84.HKD","SGXZ57979304.SGD","IE00B4R5TH58.HKD","LU0823434583.USD","LU1291159041.SGD","LU1712237335.SGD","LU0256863811.USD","IE00BKPKM429.USD","LU1061106388.HKD","SG9999015978.USD","SG9999014898.SGD","SG9999001176.USD","JDOC","LU0964807845.USD","BK4599","LU2756315664.SGD","FTXH","SG9999017495.SGD","LU2357305700.SGD","LU0079474960.USD","ELIS","LU0133085943.USD","ILDR","LU2746668461.USD","IE00BFSS8Q28.SGD","IE00BJLML261.HKD","IE00BWXC8680.SGD","LU2264538146.SGD","LU0225283273.USD","SG9999014914.USD","LU0256863902.USD","LU2756315318.SGD","SGXZ99366536.SGD","TRUH","IE0005OL40V9.USD","LU2491049909.HKD","LU0456855351.SGD","LU1093756168.USD","LU2023250504.SGD","LU2471134796.USD","IE0004445239.USD","IE00BJJMRZ35.SGD","LU0345770308.USD","LU0320765992.SGD","HRTS","BK4533","LU0882574055.USD","LU0882574139.USD","LU2028103732.USD","LU2552382058.USD","LU0353189763.USD","BK4588","LU0154236417.USD","BK4534","IE0001KFT4U8.USD","BK4007","LU1989771016.USD","LU1814569148.SGD","LU1868836914.USD","LU0106261372.USD","LU2462591350.SGD","LU0109391861.USD","LU0234572021.USD","CURE","LU0820561909.HKD","BK4516","LU2106854487.HKD","LU2468319806.SGD","LU1629891620.HKD","SG9999014880.SGD","LU1804176565.USD","LU0354030438.USD","SG9999018857.SGD","LU2746668974.SGD","LU0672654240.SGD","BK4585","IE00BK4W5L77.USD","LU0158827948.USD","LU2063271972.USD","LU1691799644.USD","LU2168564222.USD","SG9999013999.USD","LU1323610961.USD","LU1868836757.USD","LU0466842654.USD","IE00BFTCPJ56.SGD","LU0198837287.USD","LU0786609619.USD","LU0823416689.USD","LU1064131342.USD","LU2237443465.HKD","LU0820561818.USD","LU2237443895.HKD","LU0820562030.AUD","LU2361044949.HKD","GB00BDT5M118.USD","LU0109394709.USD","LU0174119429.USD","PJP","WDNA","LU2602419157.SGD","LU1280957306.USD","LU2456880835.USD","LU2023250330.USD","LU1720051017.SGD","LU2168564149.EUR","LU1623119135.USD","LU2552382215.SGD","LU2750360997.AUD","LU0316494557.USD","LU0203201768.USD","IE00B7KXQ091.USD","LU2471134879.HKD","IE00BJT1NW94.SGD","LU2168563687.JPY","RXL","LU0889565916.HKD","LU1035775433.USD","LU1127390331.HKD","LU2360106947.USD","CANC","LU1548497426.USD","LU2271345857.HKD","LU2023251221.USD","LU2087625088.SGD","LU1232071149.USD","LU2089283258.USD","IE00B2B36J28.USD","LU2896262040.SGD","LU0203202063.USD","LU1145028129.USD","LU1366192091.USD","SGXZ31699556.SGD","LU1267930730.SGD","LU0689472784.USD","LU0058720904.USD","THNR","LU0158827781.USD","LU2108987350.USD","IE00B775H168.HKD","LU0943347566.SGD","SG9999014906.USD","IHE","IE00BKVL7J92.USD","LU1974910355.USD","LU2237443622.USD","IE00BKDWB100.SGD","LU0354030511.USD","MHIP","LU1979441026.SGD","LU2471134523.USD","SGXZ81514606.USD","LU2111349929.HKD","LU2491050154.USD","SG9999001176.SGD","LU0417517546.SGD","LU2491050071.SGD","LU2361044865.SGD","LU2211815571.USD","LU0006306889.USD","TMED","LU2237443549.SGD","IE00BFSS7M15.SGD","LU0471298777.SGD","PPH","LU0640476718.USD","LU1069344957.HKD","LU1720051108.HKD","SG9999015952.SGD","LU0096364046.USD","LU1868836591.USD","LU2168564495.EUR","NVOH","BK4581","LU2237438978.USD","LU0114720955.EUR","LU1983299246.USD","SG9999015945.SGD","IE00BZ1G4Q59.USD","LU0320765059.SGD","LLYZ","SGXZ51526630.SGD","IE0004445015.USD","XLV","LU0823434740.USD","LU2168564065.EUR","IYH","IE0002141913.USD","IXJ","LU0353189680.USD","IE00B4JS1V06.HKD","LU1868837300.USD","LU0289739699.SGD","LU0238689110.USD","LU1551013342.USD","LU1988902786.USD","IE00BJJMRY28.SGD","ELIL","OZEM","LU2461242641.AUD","LU0787776722.HKD","LU2237443978.SGD","SG9999015986.USD","LU2552382132.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662639773","title":"阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2662639773","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662639773?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:08","pubTimestamp":1787810905,"startTime":"0","endTime":"0","summary":"阿斯利康的哮喘药物Tezspire在食管炎晚期临床试验中达到了所有目标路透8月27日-阿斯利康（AstraZeneca）AZN.L周四表示，其与安进（Amgen）AMGN.O联合开发的哮喘药物Tezspire，在治疗嗜酸性粒细胞性食管炎（一种食管的慢性炎症性疾病）的晚期临床试验中达到了主要和次要研究目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1015430645.USD","IBBQ","BK4599","BBH","LU1196032939.SGD","LU1064927863.SGD","LU1273509221.SGD","LU2357627491.SGD","BIB","PJP","LU0158827948.USD","LU1061106388.HKD","AMGN","LU0390134368.USD","LU0949170426.SGD","LU0960981461.USD","LU1261432733.SGD","LU0496365809.HKD","IBB","LU0882574055.USD","LU2237443549.SGD","03165","LU0640478417.SGD","LU0757432116.USD","IE00BFTCPJ56.SGD","LU0211328371.USD","IE00B2B36J28.USD","LU1323610961.USD","LU2089284900.SGD","LU1119994496.HKD","LU2125909247.SGD","LU0171276677.USD","AZN.UK","LU0011850046.USD","LU1267930813.SGD","TBXU","LU1989772840.SGD","LU0203345920.USD","BK5011","BK4139","LU0526926950.USD","LU0823416689.USD","LU1923622614.USD","LU0432979614.USD","LU0557290698.USD","PBE","BK4588","LU0211327993.USD","LU1481599808.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146489142","title":"Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果，共同主要終點及所有關鍵次要終點全面達標","url":"https://stock-news.laohu8.com/highlight/detail?id=1146489142","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146489142?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810443,"startTime":"0","endTime":"0","summary":"Tezspire在针对嗜酸性食管炎的III期临床试验中取得了令人瞩目的积极结果。该试验不仅成功达到了共同主要终点，而且所有关键次要终点也悉数告捷。Tezspire的优异表现，标志着该领域治疗可能迎来重大变革。共同主要终点的同时达成，以及关键次要终点的全面覆盖，充分验证了Tezspire的疗效一致性和临床获益的广泛性。业内专家指出，Tezspire的这项研究成果，不仅巩固了其在炎症性疾病治疗领域的地位，更可能为后续的监管审批和市场推广奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","BBH","LU1023059063.AUD","TBXU","LU1057294990.SGD","IE0002141913.USD","LU1983299246.USD","AMGN","LU2242652126.USD","IBB","LU0889565916.HKD","PBE","IE00B2B36J28.USD","LU0289739699.SGD","LU2089984988.USD","BK4581","BK4588","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0058720904.USD","LU0109394709.USD","LU0868494617.USD","LU2242646821.SGD","LU1571399168.USD","BK4533","IBBQ","LU0320765992.SGD","IE00BJT1NW94.SGD","PJP","LU1061106388.HKD","SG9999001440.SGD","BK4566","BK4585","BIB","IE00BJJMRZ35.SGD","BK4534","LU2112291526.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","BK4599","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195775229","title":"艾伯維向歐洲藥品管理局提交Skyrizi®（瑞莎珠單抗）皮下誘導治療申請，針對中重度活動性克羅恩病成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1195775229","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195775229?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810433,"startTime":"0","endTime":"0","summary":"艾伯维公司已正式向欧洲药品管理局递交了一项监管申请，旨在寻求Skyrizi皮下注射剂型的上市许可。该申请针对的适应症为——用于治疗患有中重度活动性克罗恩病的成年患者，且此方案将作为诱导治疗手段。若此次申请获得批准，Skyrizi的皮下给药方式将为患者提供更为便捷的治疗选择，有望改善治疗依从性与患者体验。此次针对克罗恩病皮下诱导治疗的申请，进一步丰富了Skyrizi的潜在临床应用范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","LU1551013342.USD","LU0310799852.SGD","LU1718418525.SGD","BK4585","LU0289961442.SGD","LU0395794307.EUR","LU1003077747.HKD","IE0002270589.USD","BK4559","LU0965509010.AUD","LU1267930490.SGD","FTXH","LU0203347892.USD","LU1496350171.SGD","IE000MB6IJN5.SGD","LU0122379950.USD","BK4534","FHLC","LU0310800379.SGD","LU2023251221.USD","LU1929549753.HKD","LU1989772923.USD","LU1037948541.HKD","LU2237443549.SGD","LU0114720955.EUR","IE00BGHQF631.EUR","IE0009355771.USD","LU1989772840.SGD","LU2237443978.SGD","LU2347655073.USD","LU1670627923.USD","IXJ","LU1236620750.USD","LU2237443895.HKD","LU1244550494.USD","SG9999003800.SGD","BK4566","TRUH","LU0124676726.USD","LU1934455194.USD","LU0057025933.USD","LU0234572021.USD","LU1057294990.SGD","LU0859254822.USD","LU0985320562.USD","LU2347655156.SGD","IE00BJT1NW94.SGD","LU0098860793.USD","JDOC","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU1923622614.USD","LU0058720904.USD","IE00BN8TJ469.HKD","LU0868494617.USD","IE000F7OJYX1.SGD","LU2112291526.USD","LU0256863811.USD","PJP","LU1061106388.HKD","LU1551013425.SGD","LU0689626769.HKD","LU0203345920.USD","LU2129689514.USD","RXL","LU0943347566.SGD","LU2125909593.SGD","LU1267930573.SGD","LU1093756168.USD","LU0170899867.USD","LU1732799900.SGD","LU1934455863.HKD","IE00BVYPNW00.USD","IE0002141913.USD","IE00B3PB1722.GBP","LU0795875086.SGD","LU0234570918.USD","BK4533","LU1037948897.HKD","LU1983299246.USD","LU0965509283.SGD","LU0795875169.SGD","LU0882574055.USD","LU0965508806.USD","LU1093756325.SGD","SG9999015952.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","IE00B2B36J28.USD","LU0432979614.USD","LU0661504455.SGD","LU0820561818.USD","LU2237443382.USD","BK4550","LU1585245621.USD","LU2237443465.HKD","SG9999015945.SGD","LU1732800096.USD","LU0708994859.HKD","LU0965509101.SGD","ABBV","LU1074936037.SGD","IE0000B7K699.USD","IE00BSNM7G36.USD","LU0198837287.USD","LU2133065610.SGD","IE000SO60NU8.SGD","IE00BLSP4452.SGD","LU0029864427.USD","PPH","IE00BBT3K403.USD","LU0738911758.USD","IE00B42XCP33.USD","LU2468319806.SGD","IE00BLSP4239.USD","IE000WAW04H5.SGD","LU0158827948.USD","LU2089984988.USD","LU1291159041.SGD","LU2433249047.HKD","LU0069063385.USD","IYH","LU0689472784.USD","LU0868494708.USD","LU0823416689.USD","LU0289739699.SGD","GLAM","LU1244550577.SGD","LU1236620834.HKD","LU1430594728.SGD","LU1162221912.USD","LU1934455277.USD","LU2087621335.USD","SG9999015978.USD","BK4581","LU0472753341.HKD","AGNG","LU0949170772.SGD","BK4139","LU0820561909.HKD","LU0553294199.USD","IE00BVYPNV92.GBP","LU0211327993.USD","LU1839511570.USD","LU1244550221.USD","LU0289739343.SGD","LU0320765646.SGD","LU0545039389.USD","MEDX","LU2237443622.USD","IE00BDGV0183.EUR","LU0511384066.AUD","BK4588","LU2129689605.HKD","SG9999011175.SGD","LU2089283258.USD","LU0726765562.USD","SG9999015986.USD","IE0004445239.USD","LU0942090050.USD","LU2089284900.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU0211328371.USD","XLV","LU0128525929.USD","LU0256863902.USD","LU2125909247.SGD","IE000BZT7R73.USD","LU0912757837.SGD","LU0417517546.SGD","LU2357627491.SGD","VHT","LU1989771016.USD","LU2129689431.USD","LU1496350502.SGD","IE00B19Z3581.USD","LU1670628061.USD","LU0861579265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662070727","title":"中國藥品監管部門受理諾和諾德口服Wegovy上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2662070727","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662070727?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 12:43","pubTimestamp":1787805817,"startTime":"0","endTime":"0","summary":"更新 1-中国药品监管部门受理诺和诺德口服Wegovy上市申请在第1至7段中补充了中国市场情况以及礼来和诺和诺德的批准信息路透上海8月27日-诺和诺德周四表示，中国药品监管部门已受理其口服版GLP-1减肥药Wegovy的上市申请。诺和诺德的Wegovy口服药已在美国和英国获得早期批准，并于今年在美国上市。诺和诺德在非工作时间未立即回应关于 中国批准Wegovy片剂可能需要多长时间的 置评请求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","IE00BFSS7M15.SGD","LU2023250504.SGD","LU0234572021.USD","PJP","LU2468319806.SGD","LU0640476718.USD","LU2264538146.SGD","LU0058720904.USD","LU0061475181.USD","IE00B4R5TH58.HKD","IE00BZ1G4Q59.USD","LU0079474960.USD","LU2471134796.USD","IE00BWXC8680.SGD","LU2168564222.USD","LU1551013342.USD","LU2461242641.AUD","SG9999017495.SGD","SGXZ99366536.SGD","LU0882574139.USD","IE0004445015.USD","IE00B4JS1V06.HKD","LU0114720955.EUR","LU2746668461.USD","LU1868837136.USD","LU0154236417.USD","BK4581","TMED","LU1804176565.USD","LU1023059063.AUD","IE00BN29S564.USD","LU0096364046.USD","LU2237443382.USD","LU0471298777.SGD","IHE","LU0323591593.USD","LU0345770993.USD","LU1814569148.SGD","LU2237438978.USD","CANC","LU2357305700.SGD","LU0158827948.USD","LU1868837300.USD","LU1366192091.USD","LU2237443549.SGD","BK4007","LU0456855351.SGD","LU2324357040.USD","LU2602419157.SGD","LU2168564065.EUR","IE00BJLML261.HKD","NVOC","LU2491050154.USD","LU2089284900.SGD","LU0786609619.USD","IE00B1BXHZ80.USD","LU0882574055.USD","LU2471134523.USD","LU0943347566.SGD","LU2028103732.USD","SG9999018865.SGD","LU1232071149.USD","LU0316494557.USD","MHIP","LU0006306889.USD","IE00B7KXQ091.USD","LU2213496289.HKD","IE0009355771.USD","NVOX","BK4588","IE0004445239.USD","IE00BJT1NW94.SGD","LU0133085943.USD","BK4532","IXJ","LU1093756325.SGD","FTXH","LU1691799644.USD","IE00BKVL7J92.USD","HRTS","LU1629891620.HKD","LU1145028129.USD","SG9999015978.USD","IE00B775H168.HKD","LU0353189763.USD","OZEM","IE00BJJMRZ35.SGD","LU0203201768.USD","LU2462157665.USD","IYH","LLYZ","LU0345770308.USD","LU2168564149.EUR","IE00BK4W5M84.HKD","LU2271345857.HKD","LU2456880835.USD","SG9999001176.SGD","BK4585","LU0820561909.HKD","LU2087625088.SGD","LU0385154629.USD","LU0471298694.HKD","LU2746668974.SGD","WDNA","IE00B2B36J28.USD","LU0820562030.AUD","LU2237443622.USD","LU2023250330.USD","LU2417539215.USD","LLYX","LU1868836591.USD","LU1548497426.USD","LU2237443895.HKD","MEDI","LU0198837287.USD","LU0708995401.HKD","LU1551013425.SGD","LU1093756168.USD","SG9999014906.USD","LU2063271972.USD","IE0002141913.USD","LU1291159041.SGD","LU0320765059.SGD","LU0256863811.USD","MEDX","TRUH","LU0320765992.SGD","LU0432979614.USD","IE00BKPKM429.USD","LU2750360997.AUD","LU0672654240.SGD","BK4534","LU0823434583.USD","LU1035775433.USD","LU2756315664.SGD","LU1127390331.HKD","LU2471134952.CNY","LU1057294990.SGD","BK4533","LU0225283273.USD","LU2552382215.SGD","LU2491049909.HKD","LU0109391861.USD","GDOC","PPH","ELIS","RXL","LU1280957306.USD","THNR","SG9999018857.SGD","LU2106854487.HKD","BK4516","LU0689472784.USD","LU2552382058.USD","LU0354030438.USD","SGXZ51526630.SGD","LLY","IE00BFSS8Q28.SGD","LU0787776722.HKD","AGNG","LU0097036916.USD","LU1064131342.USD","LU0820561818.USD","LU1623119135.USD","LU2361045086.USD","SG9999015986.USD","LU2361044865.SGD","LU0203202063.USD","IE00BJJMRX11.SGD","IE00BFTCPJ56.SGD","LU0094547139.USD","LU2211815571.USD","IE00BJJMRY28.SGD","NVO","SGXZ31699556.SGD","LU2023251221.USD","LU0210536198.USD","LU0823416689.USD","JDOC","LU1868836757.USD","SG9999001176.USD","LU0174119429.USD","LU2112291526.USD","IE0001KFT4U8.USD","IE00BK4W5L77.USD","LU2237443465.HKD","SG9999013999.USD","LU2471134879.HKD","LU1989771016.USD","LU2361044949.HKD","LU0466842654.USD","LU2360106947.USD","LU2552382132.HKD","GB00BDT5M118.USD","LU1868836914.USD","LLII","LU2168563687.JPY","SG9999014880.SGD","LU1988902786.USD","LU0289739699.SGD","VHT","LU0106261372.USD","LU0238689110.USD","BK4599","LU1069344957.HKD","LU1712237335.SGD","SGXZ81514606.USD","LU1720051108.HKD","SGXZ57979304.SGD","LU0122379950.USD","LU2236285917.USD","IE00BKDWB100.SGD","FHLC","LU1267930730.SGD","SG9999014914.USD","LU0964807845.USD","LU0158827781.USD","IE00B1XK9C88.USD","LU0256863902.USD","NVOH","ELIL","SG9999014898.SGD","LU2108987350.USD","LU2265009873.SGD","LU1979441026.SGD","LU0353189680.USD","LU2462591350.SGD","LU0823434740.USD","LU0889565916.HKD","LU2089283258.USD","CURE","LU2491050071.SGD","SG9999015952.SGD","LU1323610961.USD","SG9999015945.SGD","LU1983299246.USD","LU0354030511.USD","ILDR","IE0005OL40V9.USD","LU0109394709.USD","LU1061106388.HKD","LU2111349929.HKD","LU2750360641.GBP","LU0417517546.SGD","LU2896262040.SGD","LU0683600562.USD","LU1974910355.USD","LU2089984988.USD","XLV","LU2756315318.SGD","LU0266013472.USD","LU2168564495.EUR","LU1917777945.USD","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662875717","title":"禮來(LLY)股票8月26日開盤下跌3.57%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2662875717","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662875717?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 21:48","pubTimestamp":1787752082,"startTime":"0","endTime":"0","summary":"• 近期上涨后投资者获利回吐，导致礼来股价承压下行。 \n• 市场对于企业及商业健康保险计划能否报销肥胖症治疗费用的增长担忧依然存在。 \n• 该公司依然拥有强大的竞争护城河，长期增长前景在结构上保持完好。","market":"fut","thumbnail":"https://resource.tradingkey.com/uploads/20260204/eli-lilly-721e93ffd5ee465b8c55167d9246fe47.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/eli-lilly-721e93ffd5ee465b8c55167d9246fe47.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262133347-market-movers-lly-20260826","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","LU0385154629.USD","SG9999001176.USD","LU0353189763.USD","LU0354030438.USD","LU0820561909.HKD","LU0106261372.USD","LU0256863811.USD","LU1093756168.USD","SGXZ99366536.SGD","LU0109394709.USD","LU2108987350.USD","LU2023250330.USD","LU2456880835.USD","SGXZ31699556.SGD","LU0672654240.SGD","IE0002141913.USD","LU0058720904.USD","LU0096364046.USD","LU2491050071.SGD","LU0210536198.USD","BK4585","PJP","LU0079474960.USD","SG9999014898.SGD","SG9999015986.USD","LU0353189680.USD","LU0683600562.USD","LU2112291526.USD","SG9999001176.SGD","SG9999015945.SGD","BK4007","LU0471298694.HKD","IE00BWXC8680.SGD","LU1720051017.SGD","IE0001KFT4U8.USD","LU2471134796.USD","LU2602419157.SGD","LU1979441026.SGD","LU2746668974.SGD","LU1057294990.SGD","LU1974910355.USD","LU1064131342.USD","LU2324357040.USD","LU0174119429.USD","LU2063271972.USD","LU0820562030.AUD","IE00BK4W5M84.HKD","LU0097036916.USD","LU1988902786.USD","LU2357305700.SGD","LU2023250504.SGD","LU1989771016.USD","HRTS","FTXH","LU2750360641.GBP","LU0323591593.USD","LU1548497426.USD","MHIP","LU0203202063.USD","IE00B4R5TH58.HKD","LU1035775433.USD","IE00BJJMRZ35.SGD","IE00B1XK9C88.USD","IE00B775H168.HKD","LU0316494557.USD","LU1069344957.HKD","LU2237438978.USD","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU2236285917.USD","LU0256863902.USD","LU2471134879.HKD","LLYZ","LU0889565916.HKD","IE00BJLML261.HKD","LU2491049909.HKD","IE00BN29S564.USD","LU1868836757.USD","THNR","IE00B7KXQ091.USD","MEDX","SG9999015978.USD","LU0471298777.SGD","LU0943347566.SGD","LU1023059063.AUD","LU0964807845.USD","BK4599","LU0133085943.USD","LU0823416689.USD","LU1145028129.USD","SGXZ81514606.USD","IE0004445239.USD","BK4588","LU1691799644.USD","LU2471134523.USD","LU2756315318.SGD","LU1623119135.USD","LU2265009873.SGD","LU2746668461.USD","LU2552382215.SGD","SG9999015952.SGD","LU2750360997.AUD","LU1868837136.USD","LU2361044865.SGD","LU0823434583.USD","LU0122379950.USD","LU0320765059.SGD","LU2237443549.SGD","LU2461242641.AUD","SG9999014880.SGD","IXJ","LU0354030511.USD","LU2089984988.USD","SGXZ57979304.SGD","LU2213496289.HKD","IE00BKPKM429.USD","LU2089283258.USD","IE00BJJMRY28.SGD","BK4581","LU0820561818.USD","SGXZ51526630.SGD","LU2168564222.USD","VHT","LU2028103732.USD","FHLC","LU0689472784.USD","LU2361045086.USD","LU2023251221.USD","PPH","IE00BJJMRX11.SGD","LU2237443895.HKD","LU2468319806.SGD","LU1814569148.SGD","LLY","LU1232071149.USD","LU2168564065.EUR","LU2237443978.SGD","LU0114720955.EUR","LU0432979614.USD","LU2360106947.USD","BK4516","TMED","IYH","LU2237443622.USD","LU1551013425.SGD","LU2491050154.USD","LU2211815571.USD","ELIL","LU0234572021.USD","BK4533","LU2552382132.HKD","LU0823434740.USD","LU2417539215.USD","SG9999014906.USD","LU0345770308.USD","LU0456855351.SGD","LU2271345857.HKD","LLII","LU0158827781.USD","XLV","RXL","IE00B4JS1V06.HKD","LU1868837300.USD","LU2552382058.USD","IE00B1BXHZ80.USD","LU1712237335.SGD","IHE","LU0466842654.USD","LU0882574139.USD","LU1917777945.USD","WDNA","LU0345770993.USD","LU2361044949.HKD","LU2264538146.SGD","SG9999018857.SGD","LLYX","SG9999017495.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU1629891620.HKD","LU0198837287.USD","LU1720051108.HKD","LU2111349929.HKD","LU2168564149.EUR","LU2471134952.CNY","LU0640476718.USD","LU0708995401.HKD","MEDI","IE00BFSS7M15.SGD","LU2168564495.EUR","ELIS","LU0109391861.USD","CANC","IE00BKDWB100.SGD","LU2462157665.USD","LU1267930730.SGD","LU0006306889.USD","LU0094547139.USD","LU0786609619.USD","LU2237443382.USD","ILDR","LU2462591350.SGD","LU1983299246.USD","LU2756315664.SGD","LU1551013342.USD","SG9999013999.USD","GDOC","LU0787776722.HKD","LU1093756325.SGD","LU1868836591.USD","SG9999018865.SGD","TRUH","IE00BFSS8Q28.SGD","LU1280957306.USD","LU1291159041.SGD","LU0225283273.USD","SG9999014914.USD","LU1323610961.USD","LU0266013472.USD","LU2106854487.HKD","IE0009355771.USD","LU1804176565.USD","LU2896262040.SGD","LU2087625088.SGD","CURE","IE00BK4W5L77.USD","IE0004445015.USD","LU0417517546.SGD","LU1127390331.HKD","LU0320765992.SGD","IE0005OL40V9.USD","LU1868836914.USD","LU0158827948.USD","JDOC","OZEM","BK4534","LU1366192091.USD","LU2237443465.HKD","LU0238689110.USD","AGNG","LU0882574055.USD","LU2089284900.SGD","LU2168563687.JPY","LU0203201768.USD","GB00BDT5M118.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}